When Antibiotics Fail: India's Drug Resistance Crisis Today

The Scale of India’s Antibiotic Resistance Crisis

India is among the countries most affected by antibiotic resistance, and the situation is becoming increasingly serious. With a large population, a high number of infectious diseases, and uneven access to healthcare, antibiotics are often overused or misused. As a result, many bacteria are becoming harder to treat. Experts warn that if this trend continues, common infections that were once easily cured may become much more difficult and sometimes impossible to treat [1].

Drug-resistant infections already claim hundreds of thousands of lives across the world each year. If current trends continue, the death toll could rise sharply over the coming decades, making antibiotic resistance one of the biggest threats to global health. India is among the countries carrying a large share of this burden. Drug-resistant infections are linked to tens of thousands of infant deaths every year, highlighting how deeply the problem affects vulnerable populations [2].

What makes the antibiotic resistance in India so serious is the scale at which drugs are failing. The ICMR’s 2024 AMRSN report found that Gram-negative bacteria accounted for 72% of all bloodstream infections in Indian hospitals. Routine antibiotics, fluoroquinolones, third-generation cephalosporins, and carbapenems are now showing declining effectiveness against some of the country’s most common bacterial infections.

The rise of antibiotic resistance in India is not inevitable. But understanding what drives it is the first step towards changing course.

What Is Antibiotic Resistance and How Does It Spread?

Antibiotic resistance develops through a process of natural selection. When bacteria are exposed to an antibiotic, especially at low doses or for short periods, the weakest bacteria die, but the resistant ones survive. These survivors multiply and pass on their resistance traits.

Resistance does not stay in one place. It spreads through three main routes:

• A person who carries resistant bacteria can pass them on through contact, contaminated water, or shared food prepared under poor hygienic conditions.
• Resistant bacteria in hospital settings spread between patients via contaminated surfaces, hands, and medical equipment that has not been properly sterilised.
• Antibiotic residues from pharmaceuticals, agriculture, and livestock enter rivers and groundwater, creating environmental reservoirs of resistant bacteria that reinfect communities.
• Resistant genes can transfer between different bacterial species, meaning resistance in one type of bacteria can jump to another entirely different pathogen in the gut.
• Rural-urban migration in India actively carries resistant bacteria from farming communities, where antibiotic use in livestock is widespread, into densely populated cities.

The fact that India is both a major antibiotic producer and one of the world’s highest antibiotic consumers creates a uniquely high-risk environment for the spread of resistance.

Also read: Critical Care Unit- Expert Life-Saving Hands

The Main Causes of Antibiotic Resistance in India

Several overlapping factors drive antibiotic resistance in India, many of which are deeply embedded in how healthcare is accessed and delivered across the country.

Over-the-counter antibiotic sales

India’s Schedule H1 regulations require a prescription for antibiotics, but enforcement remains inconsistent. In many pharmacies, especially in smaller towns and villages, antibiotics are sold freely without one. Research published in Cureus confirms that over-the-counter antibiotic sales without prescription remain particularly widespread in rural India, where access to licensed doctors is limited [1].

Incomplete treatment courses

Patients frequently stop their antibiotic course early once symptoms improve. This is one of the most direct causes of antibiotic resistance, as it leaves stronger bacteria alive and able to multiply. Awareness of why the full course of treatment matters remains low, especially in communities where cost is a barrier to completing it.

Antibiotic misuse in agriculture and livestock

India’s poultry and aquaculture industries have historically used antibiotics as growth promoters, not to treat disease, but to accelerate animal weight gain. This practice exposes vast numbers of bacteria to subtherapeutic antibiotic doses, creating ideal conditions for resistance to develop. The Drug Controller General of India banned Colistin as a growth promoter in animal feed following ICMR recommendations, but broader agricultural antibiotic use continues.

Overprescription by healthcare providers

People usually expect medicines that will help them recover quickly, and antibiotics are often seen as the answer. In situations where diagnostic tests are unavailable, delayed, or too costly, antibiotics may be prescribed before the exact cause of an illness is known. This can lead to their use for conditions such as the common cold or flu, even though these illnesses are caused by viruses and do not respond to antibiotics.

Poor hospital infection control

The problem is made worse when resistant bacteria spread within healthcare facilities. Overcrowded wards, poor infection-control practices, and gaps in hygiene can allow these germs to move from one patient to another. As a result, hospital-acquired infections have become a growing concern, especially in intensive care units where patients are already vulnerable.

Why India Bears a Disproportionate Burden

Several challenges within India’s healthcare system have made antibiotic resistance harder to control.

• A large informal healthcare sector allows antibiotics to be prescribed by untrained or unlicensed practitioners, often without proper diagnosis or oversight.
• Diagnostic laboratories capable of antibiotic susceptibility testing are concentrated in urban centres, leaving most patients in rural India treated empirically without culture confirmation.
• India is the world’s largest producer of generic antibiotics and supplies over 60% of global vaccine demand, yet domestic antibiotic consumption remains poorly regulated.
• Poor sanitation, unsafe water, and inadequate waste management increase the spread of infections and resistant bacteria within communities.
• Limited awareness leads many people to self-medicate, use leftover antibiotics, or take antibiotics without proper medical advice.

Recent research notes that India’s unique combination of disease burden, population density, and healthcare diversity places it at a critical juncture in the global fight against AMR [3].

Can You Reverse Antibiotic Resistance? What the Evidence Says

A common question is whether antibiotic resistance can be reversed. The short answer is: in some cases, yes. When antibiotic pressure is reduced significantly, certain bacteria gradually lose their resistance traits over time. This has been observed in past typhoid treatment cycles, where reducing fluoroquinolone use allowed some sensitivity to return.

However, reversal is slow, incomplete, and not guaranteed. The more practical goal is to prevent resistance from advancing further. Researchers and policymakers have identified several approaches to reversing antibiotic resistance or, at a minimum, dramatically slowing its spread.

• A hospital in western Maharashtra that implemented ICMR’s antimicrobial stewardship (AMS) programme from 2021 onwards saw significant reductions in the use of multiple high-risk antibiotics, including ceftriaxone and carbapenems, alongside improved patient outcomes [2].
• The ICMR has expanded its AMS programme to 20 tertiary care hospitals across India, aiming to monitor and reduce antibiotic misuse in the most high-risk clinical settings.
• The Drug Controller General of India has banned 40 inappropriate fixed-dose combination antibiotics on ICMR’s recommendation [4].
• India’s National Action Plan on AMR (NAP-AMR) Phase 2.0, covering 2025 to 2029, continues to expand surveillance, regulate prescribing, and promote a One Health approach linking human, animal, and environmental antibiotic management [5].

These policy steps show what is possible at scale, but systemic change only works when individual behaviour follows.